Inclusive of all taxes
SIGNATURE CEFYX-0 Tablet by Dr Precision is a high-quality pharmaceutical formulation containing Cefixime, a potent third-generation cephalosporin antibiotic designed for treating a broad spectrum of bacterial infections. This tablet is specifically effective against respiratory tract infections such as pharyngitis, tonsillitis, acute and chronic bronchitis, sinusitis, and otitis media. It also targets urinary tract infections, certain gastrointestinal infections including typhoid fever, and specific sexually transmitted diseases like gonorrhea. The tablet works by inhibiting bacterial cell wall synthesis, leading to the destruction of both Gram-positive and Gram-negative bacteria. Manufactured under stringent Good Manufacturing Practices (GMP), SIGNATURE CEFYX-0 ensures consistent purity, potency, and safety, making it a reliable choice for medical professionals. It is formulated to offer optimal oral absorption and bioavailability for effective once- or twice-daily dosing. Cefixime’s resistance to beta-lactamase enzymes enables the treatment of infections caused by beta-lactamase producing resistant strains. The product is suitable for adults and children over specified medical thresholds, and it supports comprehensive infection management with a well-documented safety profile. SIGNATURE CEFYX-0 Tablets are packaged in hygienic blister strips, ensuring ease of dispensing and maintaining quality. Proper storage practices enhance shelf-life stability and effectiveness. By adhering to prescribed dosage and completing therapy, this medication helps reduce the risk of antibiotic resistance, underpinning its vital role in clinical antibacterial treatment strategies.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Cefixime - a third-generation cephalosporin antibiotic |
| Spectrum of Activity | Effective against Gram-positive and Gram-negative bacteria |
| Indications | Respiratory tract infections, urinary tract infections, gastrointestinal infections, otitis media, gonorrhea, typhoid fever |
| Mechanism of Action | Inhibits bacterial cell wall synthesis |
| Administration Route | Oral tablet for convenient outpatient therapy |
| Bioavailability | Optimized for high absorption and prolonged serum levels |
| Resistance Profile | Effective against beta-lactamase producing bacteria |
| Packaging | Blister or strip pack for hygiene and easy dispensing |
| Manufacturing Standards | Produced under GMP-compliant processes with stringent quality control |
| Safety Profile | Generally well-tolerated with monitored side effects including gastrointestinal discomfort and rare allergic reactions |
| Attributes | Description |
|---|---|
| Dosage Form | Tablet |
| Dosage Strength | Cefixime - typically 200 mg to 400 mg per tablet (dosage as per prescription) |
| Usage | Oral use |
| Target Patient Group | Adults and children above a specified age/weight as determined by medical supervision |
| Storage Conditions | Store in a cool, dry place away from direct sunlight and moisture |
| Shelf Life | As per batch-specific expiry date |
| Compliance | GMP certified |
| Side Effects | May cause nausea, diarrhea, abdominal pain; rare allergic reactions |
| Contraindications | Allergy to cephalosporins or penicillins; viral infections |
| Excretion | Primarily renal excretion - monitor renal function in impaired patients |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
SIGNATURE CEFYX-0 contains Cefixime, a third-generation cephalosporin antibiotic that exhibits stability against degradation by beta-lactamase enzymes, ensuring it remains effective against beta-lactamase producing bacterial strains where other antibiotics might fail.
Yes, SIGNATURE CEFYX-0 is suitable for use in children as prescribed by a medical professional, typically over certain age or weight thresholds to ensure safe administration.
The tablet should be stored in a cool, dry place away from direct sunlight and moisture to preserve its potency and shelf-life as specified by the manufacturer.
It is primarily used to treat respiratory tract infections (like bronchitis and sinusitis), urinary tract infections, otitis media, certain gastrointestinal infections including typhoid fever, and specific sexually transmitted infections such as gonorrhea.
Cefixime is primarily excreted through the kidneys, so renal function monitoring is recommended for patients with kidney impairment to avoid accumulation and toxicity.
Yes, completing the full prescribed course is essential even if symptoms improve early, to prevent antibiotic resistance and ensure complete eradication of the infection.
Country Of Origin: India
SIGNATURE CEFYX-0 Tablet contains Cefixime, a third-generation cephalosporin antibiotic used to treat a wide range of bacterial infections. It is effective against respiratory tract infections, urinary tract infections, ear infections, and certain sexually transmitted diseases by inhibiting bacterial cell wall synthesis, ultimately leading to the elimination of infection-causing bacteria.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
SIGNATURE CEFYX-0 Tablet is a pharmaceutical formulation that contains the active ingredient Cefixime, a broad-spectrum, third-generation cephalosporin antibiotic known for its robust effectiveness against both Gram-positive and Gram-negative bacterial pathogens. It is widely prescribed for the treatment of a variety of infections, especially those involving the respiratory tract, urinary tract, gastrointestinal system, and otolaryngological pathways. Its powerful antimicrobial action stems from its ability to inhibit bacterial cell wall synthesis, thereby weakening and ultimately destroying the bacterial cells responsible for infection.
Cefixime is particularly valuable in the treatment of conditions such as pharyngitis, tonsillitis, acute bronchitis, chronic bronchitis exacerbations, sinusitis, otitis media, urinary tract infections, gonorrhea, and certain forms of typhoid fever. The medication is administered orally, allowing for convenient outpatient therapy and high patient compliance. SIGNATURE CEFYX-0 Tablet is formulated for optimal absorption and bioavailability, ensuring that therapeutic concentrations are achieved in the bloodstream and at the site of infection.
Upon oral administration, Cefixime is absorbed moderately well and maintains prolonged serum levels, allowing for once- or twice-daily dosing depending on the severity of the infection and the physician’s judgment. The active drug is resistant to degradation by beta-lactamase enzymes produced by certain bacteria, making it a valuable option where first-line antibiotics have failed due to resistance.
SIGNATURE CEFYX-0 is suitable for use in adults and children over a specific age or weight threshold, as determined by medical professionals. The typical dosage and duration of treatment vary depending on the nature and severity of the infection. A full course of therapy should be completed even if symptoms improve before the course is finished, to prevent the emergence of antibiotic-resistant strains.
The safety profile of SIGNATURE CEFYX-0 is well-established. It is generally well-tolerated, though like all antibiotics, it may cause some side effects. Common adverse reactions include gastrointestinal discomfort, such as nausea, diarrhea, and abdominal pain. In rare cases, patients may experience allergic reactions, including rash, itching, or more serious hypersensitivity responses such as anaphylaxis. Patients with known allergies to cephalosporins or penicillins should use this medication only under strict medical supervision. Renal function should be monitored in patients with kidney impairment, as Cefixime is primarily excreted through the kidneys.
SIGNATURE CEFYX-0 should not be used to treat viral infections such as the common cold or influenza. Misuse or overuse of antibiotics may lead to the development of drug-resistant bacteria, which can compromise future treatment effectiveness. Patients are advised to follow their physician’s instructions carefully and avoid sharing the medication with others, even if they present similar symptoms.
Manufactured under Good Manufacturing Practices (GMP) and stringent quality control systems, SIGNATURE CEFYX-0 ensures consistent potency, purity, and safety in every tablet. The product is subjected to comprehensive analytical and microbiological testing before release to ensure it meets the highest international pharmaceutical standards. Each batch is validated to confirm uniformity of dosage and stability throughout its shelf life.
The tablet is conveniently packed in blister or strip formats, maintaining hygiene and ensuring easy dispensing. It is recommended that the tablet be stored in a cool, dry place, away from direct sunlight and moisture. Patients should also be advised to check the expiry date and to keep the medication out of reach of children.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze